Cargando…
Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice
BACKGROUND: The prostate cancer prevention trial (PCPT) and Reduction by dutasteride of Prostate Cancer Events (REDUCE) trial found that 5α-reductase (5αR) inhibitors finasteride and dutasteride respectively, decreased prostate cancer prevalence but also increased the incidence of high-grade tumors....
Autores principales: | Opoku-Acheampong, Alexander B., Unis, Dave, Henningson, Jamie N., Beck, Amanda P., Lindshield, Brian L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799703/ https://www.ncbi.nlm.nih.gov/pubmed/24204943 http://dx.doi.org/10.1371/journal.pone.0077738 |
Ejemplares similares
-
The impact of finasteride and dutasteride treatments on proliferation, apoptosis, androgen receptor, 5α-reductase 1 and 5α-reductase 2 in TRAMP mouse prostates
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2017) -
The Effect of Finasteride and Dutasteride on the Growth of WPE1-NA22 Prostate Cancer Xenografts in Nude Mice
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2012) -
5α-reductase 1 mRNA levels are positively correlated with TRAMP mouse prostate most severe lesion scores
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2017) -
The Different Reduction Rate of Prostate-Specific Antigen in Dutasteride and Finasteride
por: Choi, Yong Hyeuk, et al.
Publicado: (2010) -
A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
por: Antoniou, Tony, et al.
Publicado: (2018)